Dexco Holds Extraordinary Shareholder Meeting

• Dexco shareholders approved Duratex Florestal’s partial spin-off and merger of spun-off assets at an extraordinary meeting on October 26, 2026.
• Shareholders ratified Ernst & Young’s appointment and approved its valuation of R$ 38.1 million as of July 31, 2026.
• Administrators received authorization to implement the transaction, which would not change share capital or bylaws.
• Separate bylaw amendments won approval to reflect current share capital and issued shares, with an increase in the authorized capital limit.
• Shareholders endorsed renaming the IT and Digital Innovation Committee as the Transformation Committee, alongside consolidation of the amended bylaws.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dexco SA published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.